Jason Merker

Assistant Professor of Pathology at the Stanford University Medical Center
Bio:   Dr. Merker is co-director of the Stanford Medicine Clinical Genomics Service, a joint effort between Stanford Children’s Health, Stanford Health Care, and the Stanford School of Medicine. The Clinical Genomics Service is clinical and laboratory service that uses genome sequencing and other advanced molecular testing to assist in the diagnosis of genetic disease. Dr. Merker received his M.D. and Ph.D. in Genetics from the University of North Carolina at Chapel Hill. He then completed residency training in Clinical Pathology and fellowship training in Molecular Genetic Pathology and Clinical Cytogenetics at Stanford Hospital and Clinics, followed post-doctoral training in cancer genomics at Stanford University. Dr. Merker also directs a research group that focuses on two areas. First, the laboratory uses classical genetics, genomics, and functional studies to identify and characterize acquired and heritable genetic variants important for the development of hematologic disorders and other malignancies. Second, the laboratory evaluates the clinical utility of genomic and other omics-based approaches for translation into clinical care.

Professional Education

  • Postdoctoral Fellowship, Stanford University, Cancer Genomics (2012)
  • Fellowship, Stanford Hospital and Clinics, Clinical Cytogenetics (2010)
  • Fellowship, Stanford Hospital and Clinics, Molecular Genetic Pathology (2009)
  • Residency, Stanford Hospital and Clinics, Clinical Pathology (2008)
  • M.D., Ph.D., University of North Carolina School of Medicine, Medicine, Genetics (2005)
  • B.S., University of North Carolina, Chapel Hill, Biology (1996)
  • Board Certification, American Board of Medical Genetics, Clinical Cytogenetics (2011)
  • Board Certification, American Board of Pathology, Molecular Genetic Pathology (2011)
  • Board Certification, American Board of Pathology, Clinical Pathology (2009)

Honors & Awards

  • Alpha Omega Alpha Honor Medical Society, University of North Carolina School of Medicine (2004)
  • Golden Key International Honour Society, University of North Carolina, Chapel Hill (1995)
  • Phi Beta Kappa Society, University of North Carolina, Chapel Hill (1995)

Administrative Appointments

  • Co-Director of the Stanford Medicine Clinical Genomics Service, Stanford Medicine (2013 - Present)
  • Director of Test Development in Clinical Genomics, Stanford University School of Medicine (2013 - Present)
  • Molecular Oncology Committee Chair, College of American Pathologists (2015 - Present)
  • Molecular Oncology Committee Vice Chair, College of American Pathologists (2011 - 2014)

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.